Nutritional related liver disease: Targeting the endoplasmic reticulum stress

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 12, Issue 6, 2009, Pages 575-582

  Kammoun, Hélène L ^a   Hainault, Isabelle ^a   Ferré, Pascal ^a   Foufelle, Fabienne ^a,b  

^a INSERM   (France)

^b CENTRE DE RECHERCHE DES CORDELIERS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; VERY LOW DENSITY LIPOPROTEIN;

DISEASE COURSE; ENDOPLASMIC RETICULUM STRESS; FATTY ACID TRANSPORT; HUMAN; LIPOGENESIS; LIPOPROTEIN SECRETION; LIPOPROTEIN SYNTHESIS; LIVER FIBROSIS; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUTRITIONAL DISORDER; OBESITY; PATHOPHYSIOLOGY; PROTEIN FUNCTION; REVIEW;

ANIMALS; CELL SURVIVAL; CHOLESTEROL, VLDL; DISEASE PROGRESSION; ENDOPLASMIC RETICULUM; FATTY LIVER; FIBROSIS; HUMANS; INFLAMMATION; LIPOGENESIS; LIVER; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STRESS, PHYSIOLOGICAL;

RODENTIA;

EID: 70350132628     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e32833189db     Document Type: Review

References (58)

1. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006; 43 (2 Suppl 1):S99-S112.
2. Day CP, James OFW. Steatohepatitis: A tale of two 'hits'? Gastroenterology 1998; 114:842-845.
3. Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004; 40:1387-1395.
4. Schroder M, Kaufman RJ. ER stress and the unfolded protein response. Mutat Res 2005; 569 (1-2):29-63.
5. Harding HP, Zhang YH, Ron D. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 1999; 397:271-274.
6. Harding HP, Zhang YH, Bertolotti A, et al. Perk is essential for translational regulation and cell survival during the unfolded protein response. Mol Cell 2000; 5:897-904.
7. Ozcan U, Cao Q, Yilmaz E, et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004; 306:457-461.
8. Yang L, Jhaveri R, Huang J, et al. Endoplasmic reticulum stress, hepatocyte CD1d and NKT cell abnormalities in murine fatty livers. Lab Invest 2007; 87:927-937.
9. Sreejayan N, Dong F, Kandadi MR, et al. Chromium alleviates glucose intolerance, insulin resistance, and hepatic ER stress in obese mice. Obesity 2008; 16:1331-1337.
10. Han KL, Choi JS, Lee JY, et al. Therapeutic potential of peroxisome pro-liferators: activated receptor-alpha/gamma dual agonist with alleviation of endoplasmic reticulum stress for the treatment of diabetes. Diabetes 2008; 57:737-745.
11. Kammoun HL, Chabanon H, Hainault I, et al. GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. J Clin Invest 2009; 119:1201-1215.
12. Rahman SM, Schroeder-Gloeckler JM, Janssen RC, et al. CCAAT/enhancing binding protein beta deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steato hepatitis. Hepatology 2007; 45:1108-1117.
13. Puri P, Mirshahi F, Cheung O, et al. Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease. Gastroenterology 2008; 134:568-576.
14. Gregor MF, Yang L, Fabbrini E, et al. Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss. Diabetes 2009; 58:693-700.
15. Donnelly KL, Smith CI, Schwarzenberg SJ, et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005; 115:1343-1351.
16. Eberle D, Hegarty B, Bossard P, et al. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 2004; 86:839-848.
17. Foretz M, Guichard C, Ferre P, Foufelle F. Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc Natl Acad Sci U S A 1999; 96:12737-12742.
18. Hegarty BD, Bobard A, Hainault I, et al. Distinct roles of insulin and liver X receptor in the induction and cleavage of sterol regulatory element-binding protein-1c. Proc Natl Acad Sci USA 2005; 102:791-796. (Pubitemid 40282744)
19. Foretz M, Pacot C, Dugail I, et al. ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose. Mol Cell Biol 1999; 19:3760-3768.
20. ShimomuraI, BashmakovY, Horton JD. Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem 1999; 274:30028-30032.
21. Shimomura I, Matsuda M, Hammer RE, et al. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipody-strophic and ob/ob mice. Mol Cell 2000; 6:77-86.
22. Shimano H, Horton JD, Shimomura I, et al. Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J Clin Invest 1997; 99:846-854.
23. Becard D, Hainault I, Azzout-Marniche D, et al. Adenovirus-mediated over-expression of sterol regulatory element binding protein-1c mimics insulin effects on hepatic gene expression and glucose homeostasis in diabetic mice. Diabetes 2001; 50:2425-2430. (Pubitemid 33642757)
24. Higuchi N, Kato M, Shundo Y, et al. Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease. Hepatol Res 2008; 38:1122-1129
25. Ye J, Rawson RB, Komuro R, et al. ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs. Mol Cell 2000; 6:1355-1364.
26. Werstuck GH, Lentz SR, Dayal S, et al. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest 2001; 107:1263-1273.
27. Esfandiari F, Villanueva JA, Wong DH, et al. Chronic ethanol feeding and folate deficiency activate hepatic endoplasmic reticulum stress pathway in micropigs. Am J Physiol Gastrointest Liver Physiol 2005; 289:G54-G63.
28. Schroeder-Gloeckler JM, Rahman SM, Janssen RC, et al. CCAAT/en-hancer-binding protein beta deletion reduces adiposity, hepatic steatosis, and diabetes in Lepr(db/db) mice. J Biol Chem 2007; 282:15717-15729.
29. Chen C, Dudenhausen EE, Pan YX, et al. Human CCAAT/enhancer-binding protein beta gene expression is activated by endoplasmic reticulum stress through an unfolded protein response element downstream of the protein coding sequence. J Biol Chem 2004; 279:27948-27956.
30. Lee AH, Scapa EF, Cohen DE, Glimcher LH. Regulation of hepatic lipogenesis by the transcription factor XBP1. Science 2008; 320: 1492-1496.
31. Bobrovnikova-Marjon E, Hatzivassiliou G, Grigoriadou C, et al. PERK-depen-dent regulation of lipogenesis during mouse mammary gland development and adipocyte differentiation. Proc Natl Acad Sci USA 2008; 105:16314-16319.
32. Oyadomari S, Harding HP, Zhang YH, et al. Dephosphorylation of translation initiation factor 2 alpha enhances glucose tolerance and attenuates hepa-tosteatosis in mice. Cell Metab 2008; 7:520-532.
33. OtaT, Gayet C, Ginsberg HN. Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents. J Clin Invest 2008; 118:316-332.
34. Qiu W, Su Q, Rutledge AC, et al. Glucosamine-induced ER stress attenuates apolipoprotein B100 synthesis via PERK signaling. J Lipid Res 2009 [Epub ahead of print]
35. Sharma NK, Das SK, Mondal AK, et al. Endoplasmic reticulum stress markers are associated with obesity in nondiabetic subjects. J Clin Endocrinol Metab 2008; 93:4532-4541.
36. Boden G, Duan X, Homko C, et al. Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals. Diabetes 2008; 57:2438-2444.
37. Zhou QG, Zhou M, Hou FF, Peng X. Asymmetrical dimethylarginine triggers lipolysis and inflammatory response via induction of endoplasmic reticulum stress in cultured adipocytes. Am J Physiol Endocrinol Metab 2009;296:E869-E878.
38. Jo H, Shim J, Lee JH, et al. IRE-1 and HSP-4 contribute to energy homeostasis via fasting-induced lipases in C. elegans. Cell Metab 2009; 9:440-448.
39. Urano F, Wang X, Bertolotti A, Zhang Y, et al. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 2000; 287:664-666.
40. Hirosumi J, Tuncman G, Chang L, et al. A central role for JNK in obesity and insulin resistance. Nature 2002; 420:333-336.
41. Wei Y, Wang D, Gentile CL, Pagliassotti MJ. Reduced endoplasmic reticulum luminal calcium links saturated fatty acid-mediated endoplasmic reticulum stress and cell death in liver cells. Mol Cell Biochem 2009 [Epub ahead of print]
42. Wei Y, Wang D, Topczewski F, Pagliassotti MJ. Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. Am J Physiol Endocrinol Metab 2006; 291:E275-E281. (Pubitemid 44035286)
43. Lemoine M, Ratziu V, Kim M, et al. Serum adipokine levels predictive of liver injury in nonalcoholic fatty liver disease. Liver Int 2009 [Epub ahead of print]
44. Tarantino G, Conca P, Pasanisi F, et al. Could inflammatory markers help diagnose nonalcoholic steatohepatitis? Eur J Gastroenterol Hepatol 2009; 21:504-511.
45. Cardozo AK, Ortis F, Storling J, et al. Cytokines downregulate the sarcoen-doplasmic reticulum pump Ca2+ ATPase 2b and deplete endoplasmic reticulum Ca2+, leading to induction of endoplasmic reticulum stress in pancreatic beta-cells. Diabetes 2005; 54:452-461.
46. Eizirik DL, Cardozo AK, Cnop M. The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev 2008; 29:42-61.
47. Tajiri K, Shimizu Y, Tsuneyama K, Sugiyama T. Role of liver-infiltrating CD3+CD56+ natural killer T cells in the pathogenesis of nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 2009; 21:673-680.
48. Watanabe Y, Suzuki O, Haruyama T, Akaike T. Interferon-gamma induces reactive oxygen species and endoplasmic reticulum stress at the hepatic apoptosis. J Cell Biochem 2003; 89:244-253.
49. Zhang K,Shen X, WuJ,et al. Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response. Cell 2006; 124: 587-599.
50. Kogiso T, Moriyoshi Y, Shimizu S, et al. High-sensitivity C-reactive protein as a serum predictor of nonalcoholic fatty liver disease based on the Akaike Information Criterion scoring system in the general Japanese population. J Gastroenterol 2009; 44:313-321.
51. Riquelme A, Arrese M, Soza A, et al. Nonalcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics. Liver Int 2009; 29:82-88.
52. Casoinic F, Sampelean D, Badau C. Glycoregulation disorders and alterations of C reactive protein in nonalcoholic fatty liver disease. Rom J Intern Med 2006; 44:419-426.
53. Yoneda M, Mawatari H, Fujita K, et al. High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH. J Gastroenterol 2007; 42:573-582.
54. Schattenberg JM, Singh R, Wang Y, et al. JNK1 but not JNK2 promotes the development of steatohepatitis in mice. Hepatology 2006; 43:163-172.
55. Kodama Y, Kisseleva T, Iwaisako K, et al. JNK1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in ice. Gastroenterology 2009 [Epub ahead of print]
56. Ji C, Mehrian-Shai R, Chan C, et al. Role of CHOP in hepatic apoptosis in the murine model of intragastric ethanol feeding. Alcohol Clin Exp Res 2005; 29:1496-1503.
57. Ozcan U, Yilmaz E, Ozcan L, et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 2006; 313:1137-1140.
58. Rutkowski DT, Wu J, Back SH, et al. UPR pathways combine to prevent hepatic steatosis caused by ER stress-mediated suppression of transcrip tional master regulators. Dev Cell 2008; 15:829-840.